Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Net Margin
Mayinglong Pharmaceutical Group Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 12B CNY |
| Net Margin |
15%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 698.5B USD |
| Net Margin |
17%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | DK |
| Market Cap | 3.8T DKK |
| Net Margin |
36%
|
| Country | US |
| Market Cap | 359.3B USD |
| Net Margin |
45%
|
| Country | US |
| Market Cap | 322.8B USD |
| Net Margin |
4%
|
| Country | UK |
| Market Cap | 186.8B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 179.8B CHF |
| Net Margin |
32%
|
| Country | CH |
| Market Cap | 173.2B CHF |
| Net Margin |
20%
|
| Country | US |
| Market Cap | 157B USD |
| Net Margin |
-1%
|
Profitability Report
View the profitability report to see the full profitability analysis for Mayinglong Pharmaceutical Group Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Mayinglong Pharmaceutical Group Co Ltd's most recent financial statements, the company has Net Margin of 15.1%.
You don't have any saved screeners yet
